|
|
||||||||
IIb
3-Binding Fragments Derived from Immunized Donors Using Phage Display1




*
Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5533, Hopital Cardiologique, Pessac, France;
German Cancer Research Center, Recombinant Ab Group, Heidelberg, Germany; and
Department of Cardiology, University of Freiburg, Freiburg, Germany
Previous studies of the immune response in polytransfused Glanzmann
thrombasthenia (GT) patients and in autoimmune thrombocytopenic purpura
(AITP) have relied on serum analysis and have shown the frequent
development of Abs directed against the
IIb
3 integrin. However, little is known
about the molecular diversity of the humoral immune response to
IIb
3 due to the paucity of mAbs issuing
from these pathologies. We have isolated human IgG
anti-
IIb
3 binding fragments using
combinatorial libraries of single-chain IgG created from the B cells of
a GT and an AITP patient, both with serum Abs. Ab screening was
performed using activated platelets or activated
IIb
3-expressing Chinese hamster ovary
cells. Sequencing of selected phage Abs showed that a broad selection
of genes from virtually all V gene families had
been used, indicating the diversity of the immune response. About
one-half of the VH and
VL segments of our IgG
anti-
IIb
3 fragments displayed
extensive hypermutations in the complementarity-determining region,
supporting the idea that an Ag-driven immune response was occurring in
both patients. The H chain complementarity-determining region 3
analysis of phage Abs revealed motifs other than the well-known RGD and
KQAGDV integrin-binding sequences. To our knowledge, our study is the
first to illustrate multiple human IgG
anti-
IIb
3 reactivities and structural
variations linked to the anti-platelet human immune response. Human
IIb
3 Abs preferentially directed against
the activated form of the integrin were further characterized because
platelet
IIb
3 inhibitors are potential
therapeutic reagents for treating acute coronary syndromes. Currently
available
IIb
3 antagonists do not
specifically recognize the activated form of the
integrin.
This article has been cited by other articles:
![]() |
Z. Li, M. A. Nardi, J. Wu, R. Pan, W. Zhang, and S. Karpatkin Platelet Fragmentation Requires a Specific Structural Conformation of Human Monoclonal Antibody against {beta}3 Integrin J. Biol. Chem., February 8, 2008; 283(6): 3224 - 3230. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Chen, C.-X. Sun, and J.-N. Liu A Novel Anti-platelet Monoclonal Antibody (3C7) Specific for the Complex of Integrin {alpha}IIb{beta}3 Inhibits Platelet Aggregation and Adhesion J. Biol. Chem., July 8, 2005; 280(27): 25403 - 25408. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |